Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis.
Gabriel BstehKlaus BerekHarald HegenPatrick AltmannSebastian WurthMichael AuerAnne ZinganellFranziska Di PauliPaulus Stefan RommerFritz LeutmezerFlorian DeisenhammerThomas BergerPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)
We present evidence that cross-sectionally measured mGCIPL thickness and annualized thinning rates of mGCIPL are able to identify clinically progressing RMS with high accuracy.